Mr Mrs Miss Ms Dr Other

Dr
Clara
Orofino Peña

Patent Director

Glasgow Office

Chemistry

Telephone. +44(0) 141 229 5800
Email. corofino@hgf.com
Vcard
Linkedin

Experience

Clara has extensive experience drafting and prosecuting patent applications in the fields of pharmaceuticals, process chemistry, materials chemistry, textiles, alternative proteins, batteries and fuel cells, surfactants, medical devices and other mechanical devices.

She manages global IP portfolios in a variety of technologies for universities, SMEs and multinationals, and her main body of work is European and UK patent drafting and prosecution for multinationals and foreign associates. Clara also has experience in patentability and freedom to operate opinions, European patent oppositions and appeals.

Clara speaks multiple languages and enjoys providing focused technical and commercial advice to her clients.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
Europe

BSC

Pure and Applied Chemistry - University of Strathclyde

PHD

PhD in Materials Chemistry - University of Strathclyde

POSTGRADUATE DIPLOMA OR CERTIFICATE

IPReg Intellectual Property Litigation Certificate (UK)

OTHER

Licenciatura en Quimica (Equivalent to MSci in Pure and Applied Chemistry) - University of the Basque Country

Recognition

Managing IP Rising Star 2023

Clara was awarded an IP Rising Star from Managing IP star awards in 2022, 2023, and 2024

View recognition online

Publications

12 HGF Attorneys Recognised as Managing IP Rising Stars 2025

View publication online

Protecting inventions in Europe and beyond

View publication online

Celebrating Success – Director Promotions

View publication online

Managing IP Rising Stars 2024

View publication online

More Exam Success at HGF!

View publication online

Managing IP's Rising Stars 2021

View publication online

Star-shaped oligofluorene truxene macromolecules – synthesis and properties as a function of alkyl chain length

View publication online

A saturated red color converter for visible light communication using a blend of star-shaped organic semiconductors

View publication online

Fluorene-containing tetraphenylethylene molecules as lasing materials

View publication online

Fluorescent Red-Emitting BODIPY Oligofluorene Star-Shaped Molecules as a Color Converter Material for Visible Light Communications

View publication online

Location, Location, Location - Strategic Positioning of 2,1,3-Benzothiadiazole Units within Trigonal Quaterfluorene-Truxene Star-Shaped Structures

View publication online

Mechanically Flexible Organic Semiconductor Laser Array

View publication online

A saturated red color converter for visible light communication using a blend of star-shaped organic semiconductors

View publication online

BODIPY star-shaped molecules as solid state colour converters for visible light communications

View publication online

CSR

Clara has mentored trainees on drafting and prosecution matters and has delivered tutorials for the EQE paper B.

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

Read article
Event - 14th October 2025

The Future of Protein Production Amsterdam 2025

HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

Event details

A Turning Point for AI Patent Eligibility?

Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

Read article

T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us